Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Abstract Cell-based immunotherapies (CBIs), notably exemplified by chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy, have emerged as groundbreaking approaches for cancer therapy. Nevertheless, akin to various other therapeutic modalities, tumor cells employ counterstrategies to mani...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
BMC
2024-01-01
|
| Edice: | Journal of Biomedical Science |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12929-024-00998-8 |